tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.
GEHC · Q3 2025 Earnings
GE HealthCare
Reported October 29, 2025
Headline numbers
Key financials
Q3 FY2025| Metric | Q3 FY2025 | YoY | Q2 FY2025 | QoQ |
|---|---|---|---|---|
| Revenue | $5.14B | +6.0% | $5.01B | +2.7% |
| EPS | $1.07 | — | $1.06 | +0.9% |
| Gross margin | 38.7% | — | 39.6% | -90bps |
| Operating margin | 12.7% | — | 13.1% | -40bps |
| Free cash flow | $0.48B | — | $0.01B | +6800.0% |
Guidance
Q3 beat organic revenue and EPS expectations; full-year FY2025 guidance narrowed upward with reaffirmed organic growth and profitability targets.
Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.
Actuals vs prior guidance
| Metric | Period | Prior guide | Actual | Δ | Result |
|---|---|---|---|---|---|
| Organic Revenue Growth | Q3 FY2025 | 2% to 3% | 4% | +1 pt above high end of guide | Beat |
| Adjusted EPS | Q3 FY2025 | decline high single digits YoY | 1.07 | Exceeded qualitative decline guidance; Q3 EPS grew vs guidance expectation despite tariff headwinds | Beat |
New guidance
| Metric | Period | Guide | YoY |
|---|---|---|---|
| Organic Revenue Growth | Q4 FY2025 | 3% to 4% | — |
Reaffirmed unchanged this quarter: Adjusted EPS ($4.51 to $4.63), Organic Revenue Growth (approximately 3%), Adjusted EBIT Margin (15.2% to 15.4%), Adjusted Effective Tax Rate (20% to 21%), Free Cash Flow (at least $1.4 billion)
Segment KPIs
Q3 FY2025| Segment | Q3 FY2025 | YoY |
|---|---|---|
| Imaging | $2.349B | +4.0% |
| Advanced Visualization Solutions | $1.301B | +6.0% |
| Patient Care Solutions | $0.731B | -7.0% |
| Pharmaceutical Diagnostics | $0.749B | +10.0% |
Other KPIs
Q3 FY2025| Segment | Q3 FY2025 |
|---|---|
| Organic Revenue Growth | 4% |
| Organic Orders Growth | 6% |
| Book-to-Bill Ratio | 1.06x |
| Adjusted EBIT Margin | 14.8% |
| Net Income Margin | 8.7% |
| Operating Cash Flow | $593 million |
| Tariff Impact on Adjusted EBIT | $265 million FY headwind |
| Tariff Impact on Adjusted EPS | $0.45 FY headwind |
Management tone
Answers to last quarter's watch list
What to watch into next quarter
Sources
- GE HealthCare Q3 2025 earnings press release, filed with SEC: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000052/release3q25earnings.htm
Get the next brief, free.
We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.
This is not investment advice.